[HTML][HTML] Caveolae-Mediated Extracellular Vesicle (CMEV) Signaling of Polyvalent Polysaccharide Vaccination: A Host–Pathogen Interface Hypothesis
SC Li, MH Kabeer - Pharmaceutics, 2022 - mdpi.com
We published a study showing that improvement in response to splenectomy associated
defective, in regards to the antibody response to Pneumovax® 23 (23-valent …
defective, in regards to the antibody response to Pneumovax® 23 (23-valent …
Pneumococcal polysaccharide vaccine prevents ACS events in elderly, saves cost
S Ren - PharmacoEconomics & Outcomes News, 2021 - Springer
Pneumococcal polysaccharide vaccine (PPV) is a cost-saving strategy for the prevention of
acute coronary syndrome (ACS) in the elderly in Australia, report researchers from the …
acute coronary syndrome (ACS) in the elderly in Australia, report researchers from the …